Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
about
HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinomaTransfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategyPhenytoin as a novel anti-vitiligo weaponHuman dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity.Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Strategies and challenges in eliciting immunity to melanoma.The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.Vitiligo puzzle: the pieces fall in place.Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligoVitiligo road map.A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.Evidence for an autoimmune pathogenesis of vitiligo.GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1.Self-representation in the thymus: an extended view.Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India.Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patientsCD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis.Gene expression signature for spontaneous cancer regression in melanoma pigsSystemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.A Comparison of Betamethasone Valerate 0.1% Cream Twice Daily Plus Oral Simvastatin Versus Betamethasone Valerate 0.1% Cream Alone in the Treatment of Vitiligo PatientsDisulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductaseVitiligo: a review of some facts lesser known about depigmentation.Innate immune mechanisms in vitiligo: danger from within.Regulatory T-cell cytokines in patients with nonsegmental vitiligo.Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients.Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients.Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.Association between FOXP3 polymorphisms and vitiligo in a Han Chinese population.Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
P2860
Q24315946-B6B7C35A-FAB9-4598-960D-CAED774C47BFQ24814910-655448A0-2686-402E-9B5C-770936D93AD6Q24815549-F3FE192E-8F9C-4C8B-B61E-68ECF50E20D6Q30426385-4FFF57E9-ECF2-4F83-BAAB-DDB33A26E5ACQ30433217-48BF1BA9-5894-4557-B36B-DCD0248BE6BAQ30435893-884D1D74-7F60-496E-A11B-8A083149385FQ30829628-DA7B70A3-FFBD-4422-B6C2-C33A82002DD2Q33344607-500D8169-5554-4F7D-ABDB-17A188ADEA47Q34020057-E34C1897-6FCB-4895-B44F-03D748C67AA3Q34287499-A1751868-DAA2-4E8A-87A0-9B534994C7A2Q34511375-9B119057-BC5C-481A-8490-8A55DA565873Q34535453-793C0CCB-846A-4784-A515-3483529C9EB3Q34692289-BF3766F0-843A-4307-9EDA-7B5CB36BFF18Q35005955-6E5AE9F8-86EC-4715-99CC-9FABE216A346Q35080073-ACDA73EA-04A1-40E9-9FBE-77F1729AEE56Q35552274-588489B0-A2A4-4954-8798-20713766F201Q35877206-58FC7271-25A2-4917-A156-C5C4C1561821Q35998016-C4F7BFA4-3DD9-4241-9FB5-5BEA116565FAQ36349548-A8CF5B85-7C05-4DD1-B129-346CCACA06EEQ36575593-6B7DFAB8-5CA7-485C-A6AD-AD13C07165E7Q36610648-343DA2B2-92AA-470C-9471-FEB6E4B8C623Q36652524-82C37513-5E80-4560-9616-63518118BFBFQ36730956-C1CD5FC2-2675-4B10-AF9D-A0484901B940Q37240967-0CB9E835-8AA7-4EF6-A5DF-1662BFF62162Q37399612-9EB3FDC6-41F5-4798-AEA9-6AE761ABD736Q37611016-6CF0EE4F-5FD8-4384-BD25-AE5C8376CEBAQ37743574-78D76101-ED11-4CB5-9830-913CA3B99207Q37867108-762254AD-1667-4CC4-AEDD-597F1120F017Q37895910-A0C18665-164D-4A1A-BE0C-A4AC9A55655CQ38163168-A4516FE1-D19F-48AA-BEEA-78CEF86C0BBCQ38752083-39C273C6-616D-4C1D-90AE-86F661717962Q39412203-4D72A7B5-B615-4443-A4F3-BD83628EB161Q39419931-2DBC720B-3457-47F5-BFD1-D82CCCEE4C08Q40282263-D78EF298-2545-4B4C-9195-F132C6717E19Q40439479-899356E3-0D29-4ECD-B687-EC197BE19322Q42619484-87B77F22-28C3-4314-B852-0B977F120C3AQ42636087-9048AB2B-745D-4943-9B30-438FA18F63B9Q44116002-6B57D6AF-83F8-4652-B8DD-9D47DCB4DBB9Q44733789-9EA9FF3A-6946-4FE2-BDB7-3C1C4228FC54Q45914002-216F1732-FC03-498C-8AB7-08DF799F151C
P2860
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Specific cytotoxic T lymphocyt ...... etiopathogenesis of vitiligo.
@en
type
label
Specific cytotoxic T lymphocyt ...... etiopathogenesis of vitiligo.
@en
prefLabel
Specific cytotoxic T lymphocyt ...... etiopathogenesis of vitiligo.
@en
P2093
P50
P1476
Specific cytotoxic T lymphocyt ...... e etiopathogenesis of vitiligo
@en
P2093
Garbelli S
Giachino C
Lantelme E
Martinetti M
P304
P356
10.1046/J.1523-1747.2001.01408.X
P407
P577
2001-08-01T00:00:00Z
P5875
P6179
1039594307